Received Jul 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 1 | — | IM / LG |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | — | IM / LG |
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | PO / MO |
Significant rash developed that was most consistent with eczema. Patient was seen in clinic for evaluation. No threat to life.